Association between hedonic hunger and glycemic control in non-obese and obese patients with type 2 diabetes

被引:12
|
作者
Cheung, Lorena Tsui Fun [1 ]
Ko, Gary Tin Choi [1 ]
Chow, Francis Chun Chung [1 ]
Kong, Alice Pik Shan [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
关键词
Hedonic hunger; Obesity; Type; 2; diabetes; WEIGHT; POWER; RISK;
D O I
10.1111/jdi.12800
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/IntroductionHigher hedonic hunger has been observed in obese individuals compared with those without obesity, but little is known about its association with glycemic management. We aimed to examine the association between hedonic hunger and glycemic control in non-obese and obese patients with type 2 diabetes. Materials and MethodsBetween April and November 2016, a total of 211 type 2 diabetes patients who underwent comprehensive diabetes assessments at a university-affiliated hospital were recruited into two groups according to body mass index: non-obese (body mass index 18.5-24.9kg/m(2)) and obese (body mass index 30kg/m(2)) groups. All participants completed the Chinese version of the Power of Food Scale (PFS) for assessment of hedonic hunger. Good glycemic control was defined as glycated hemoglobin <7.0%. ResultsCompared with the non-obese group, the obese group showed higher PFS aggregated and subscale food available' scores (both P<0.05). After adjustment for age, sex, disease duration of diabetes and insulin use, there were positive associations of glycated hemoglobin with PFS aggregated, subscale food available' and food present' scores in the obese group (all P for trend <0.05). The PFS aggregated score was negatively associated with good glycemic control in obese type 2 diabetes patients after adjustment using logistic regression analysis (adjusted odds ratio 0.42, 95% confidence interval 0.20-0.91, P=0.027). By contrast, such associations were not observed in non-obese type 2 diabetes patients. ConclusionsHedonic hunger had an independent and inverse association with good glycemic control in obese Chinese patients with type 2 diabetes, but not in their counterparts without obesity.
引用
收藏
页码:1135 / 1143
页数:9
相关论文
共 50 条
  • [21] Relationship between uric acid and visceral fat in obese and non-obese type 2 diabetic patients
    Pankiv, VI
    Sydorchuk, IJ
    Kyryliuk, MD
    DIABETOLOGIA, 2001, 44 : A181 - A181
  • [22] Type 2 diabetes in the non-obese children and adolescents in Bangladesh
    Sayeed, M. A.
    Mahtab, H.
    Banu, A.
    Khanam, P. A.
    Latif, Z. A.
    Ahmed, A. U.
    Nahar, J. S.
    Khatun, K.
    Khan, A. Azad
    DIABETOLOGIA, 2008, 51 : S175 - S175
  • [23] Association Between 25-Hydroxyvitamin D and Epicardial Adipose Tissue in Chinese Non-Obese Patients with Type 2 Diabetes
    Chen, Xiong
    Wu, Wenjun
    Wang, Luyin
    Shi, Yujuan
    Shen, Feixia
    Gu, Xuemei
    Jia, Zhijun
    MEDICAL SCIENCE MONITOR, 2017, 23 : 4304 - 4311
  • [24] Serum levels of fibronectin and endothelin-1 in obese and non-obese patients with Type 2 diabetes mellitus
    Mogylnytska, L
    Mankovsky, B
    DIABETOLOGIA, 2004, 47 : A455 - A456
  • [25] Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients
    Dominique Hansen
    Paul Dendale
    Milou Beelen
    Richard A. M. Jonkers
    Annelies Mullens
    Luk Corluy
    Romain Meeusen
    Luc J. C. van Loon
    European Journal of Applied Physiology, 2010, 109 : 397 - 404
  • [26] Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients
    Hansen, Dominique
    Dendale, Paul
    Beelen, Milou
    Jonkers, Richard A. M.
    Mullens, Annelies
    Corluy, Luk
    Meeusen, Romain
    van Loon, Luc J. C.
    EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2010, 109 (03) : 397 - 404
  • [27] Molecular profiling between obese and non-obese PWS patients
    Kim, Minji
    Yoon, Ju Young
    Yoo, Suk Dong
    Cheon, Chong Kun
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 74 - 74
  • [28] Significant Differences in Effects of Sitagliptin Treatment on Body Weight and Lipid Metabolism Between Obese and Non-Obese Patients With Type 2 Diabetes
    Katsuyama, Hisayuki
    Adachi, Hiroki
    Hamasaki, Hidetaka
    Moriyama, Sumie
    Sako, Akahito
    Yanai, Hidekatsu
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2014, 4 (5-6) : 136 - 142
  • [29] DIFFERENCES BETWEEN OBESE AND NON-OBESE PATIENTS WITH IDIOPATHIC GASTROPARESIS
    Parkman, Henry P.
    Hallinan, Erin
    Hasler, William L.
    Farrugia, Gianrico
    Koch, Kenneth L.
    Nguyen, Linda Anh B.
    Snape, William J.
    Abell, Thomas
    McCallum, Richard W.
    Sarosiek, Irene
    Miriel, Laura
    Tonascia, James
    Hamilton, Frank A.
    Pasricha, Pankaj J.
    GASTROENTEROLOGY, 2017, 152 (05) : S517 - S518
  • [30] Different β-cell secretory phenotype in non-obese compared to obese early type 2 diabetes
    Gudipaty, Lalitha
    Rosenfeld, Nora K.
    Fuller, Carissa S.
    Cuchel, Marina
    Rickels, Michael R.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (05)